BOSULIF
NDC 63539-193, Bosutinib, tablet, film coated, from U.S. Pharmaceuticals.
- Product NDC
- 63539-193
- Status
- Listed
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203341
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63539-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BOSUTINIB MONOHYDRATE400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63539-193-30 | 63539019330 | 30 TABLET, FILM COATED in 1 BOTTLE (63539-193-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d5929f91-6496-4c0e-97e8-0bd524e15763
Use it
Look up 63539-193 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63539-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63539-193. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.